Literature DB >> 18431072

Variants of parvovirus B19: bioinformatical evaluation of nested PCR assays.

Massimiliano Bergallo1, Cristina Costa, Francesca Sidoti, Mauro Novelli, Renata Ponti, Carlotta Castagnoli, Chiara Merlino, Maria Grazia Bernengo, Rossana Cavallo.   

Abstract

Variants of parvovirus B19 are currently grouped into three genotypes: 1 (reference B19 strains), 2 and 3. It has been evidenced that isolate K71 of genotype 2 is more prevalent in skin than the conventional B19 genotype 1. In this study we investigated the detection of parvovirus B19 genotypes by using two nested PCRs and evaluating the suitability of these assays by BLAST search of parvovirus isolates. Subsequently, we analyze the present genotypes in skin biopsies. The two nested PCRs employed in this study allow to amplify 41 isolates as confirmed by bioinformatical validation. The molecular epidemiological characterization of our casistics confirmed the presence of isolate K71 in human skin. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18431072     DOI: 10.1159/000127429

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  3 in total

1.  Parvovirus b19 persistence in abnormal thyroid tissue of a mature cystic ovarian teratoma: a case report.

Authors:  Laura A Adamson-Small; Larry J Fowler; Jacqueline A Hobbs
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

2.  Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients.

Authors:  Bianca E Gama; Vanessa E Emmel; Michelle Oliveira-Silva; Luciana M Gutiyama; Leonardo Arcuri; Marta Colares; Rita de Cássia Tavares; Luis F Bouzas; Eliana Abdelhay; Rocio Hassan
Journal:  Transplant Direct       Date:  2017-10-02

3.  Detection of parvovirus B19 in the lower respiratory tract.

Authors:  Cristina Costa; Maria Elena Terlizzi; Paolo Solidoro; Daniela Libertucci; Massimiliano Bergallo; Rossana Cavallo
Journal:  J Clin Virol       Date:  2009-07-24       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.